NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT01598454 2015-07-29Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated GangliosidesLaboratorio Elea Phoenix S.A.Phase 1 Completed15 enrolled
NCT00831844 2015-03-30Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed116 enrolled 8 charts